Cellular Apoptosis Susceptibility (chromosome Segregation 1-like, CSE1L) Gene is a Key Regulator of Apoptosis, Migration and Invasion in Colorectal Cancer
Authors
Affiliations
Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene maps to chromosomal region 20q13.13, a region frequently amplified in solid tumours. In this study, we investigated the roles played by CSE1L in colorectal cancer by examining CSE1L expression and clinico-pathological parameters in colorectal cancer and investigating the effect of CSE1L on the viability, adhesion and migration of colorectal cancer cells. RT-PCR showed that CSE1L mRNA was over-expressed in colorectal cancer. CSE1L depletion by knock-down with CSE1L-specific siRNA significantly reduced viability in HCT116 cells (p = 0.004) and SW480 cells (p = 0.003) whilst significantly increasing the proportion of apoptotic HCT116 cells (p < 0.001) and SW480 cells (p < 0.001). Furthermore, CSE1L depletion significantly reduced the adhesive capacity of HCT116 (p = 0.003) and SW480 cells (p = 0.004). Analysis by qRT-PCR following CSE1L siRNA treatment of HCT116 and SW480 cells showed significant modulation of key apoptotic (p53, p73 and BAK) and adhesive (E-cadherin, Ep-CAM and ICAM-1) molecules. Immunohistochemistry of a colorectal cancer tissue microarray showed that CSE1L had a significantly increased level in colorectal cancer compared to normal colorectal epithelium (p < 0.001). There were significant decreases in both nuclear (p = 0.006) and cytoplasmic (p = 0.003) staining of CSE1L in tumours with lymph node metastasis (stage 3 tumours) compared with lymph node-negative tumours (stage 1 and 2 tumours). In lymph node-negative patients, poor survival was associated with increased CSE1L cytoplasmic expression (p = 0.042). These results indicate that CSE1L is associated with viability and apoptosis, cellular adhesion and invasion, thus implicating CSE1L in the progression of colorectal cancer.
Kalia P, Nair R, Yadav S Discov Oncol. 2025; 16(1):21.
PMID: 39776001 PMC: 11711428. DOI: 10.1007/s12672-025-01748-4.
Wang D, Liufu J, Yang Q, Dai S, Wang J, Xie B Biol Direct. 2022; 17(1):29.
PMID: 36319976 PMC: 9628086. DOI: 10.1186/s13062-022-00342-w.
Interfering with CSE1L/CAS inhibits tumour growth via C3 in triple-negative breast cancer.
Ye M, Chen Y, Liu J, Tian J, Wang X, Fok K Cell Prolif. 2022; 55(5):e13226.
PMID: 35403306 PMC: 9136492. DOI: 10.1111/cpr.13226.
Salvi A, Young A, Huntsman A, Pergande M, Korkmaz M, Rathnayake R Cell Death Dis. 2022; 13(1):45.
PMID: 35013112 PMC: 8748433. DOI: 10.1038/s41419-021-04495-w.
Long Non-Coding RNA: A Potential Strategy for the Diagnosis and Treatment of Colorectal Cancer.
Chen S, Fang Y, Sun L, He R, He B, Zhang S Front Oncol. 2021; 11:762752.
PMID: 34778084 PMC: 8578871. DOI: 10.3389/fonc.2021.762752.